Mechanism of hypoprothrombinemia and hypoproconvertinemia in experimental thyrotoxicosis

  • N. N. Petrishchev
  • V. I. Kiyanov
Pathological Physiology and General Pathology
  • 13 Downloads

Abstract

Indices of the thromboelastogram (TEG) and the activity and breakdown of prothrombin and proconvertin in experimental thyrotoxicosis were studied in experiments on rats. In the presence of marked thyrotoxicosis most of the indices of the TEG shifted toward hypocoagulation: thrombin formation was slowed, the total coagulation constant was increased, and maximal amplitude was reduced. A decrease in the activity and intensified breakdown of prothrombin and, in particular, of proconvertin also were observed. It is postulated that increased destruction of these factors plays a fundamental role in the pathogenesis of the hypoprothrombinemia and hypoproconvertinemia accompanying thyrotoxicosis.

Key Words

prothrombin proconvertin thyrotoxicosis 

Literature Cited

  1. 1.
    A. K. Gorchakov and R. M. Glants, Vrach. Delo, No. 9, 623 (1946).Google Scholar
  2. 2.
    A. A. Diyarova, in: Proceedings of a Scientific Conference of Azerbaijan Medical Institute [in Russian], Vol. 3, Baku (1972), p. 123.Google Scholar
  3. 3.
    V. A. Zhulkevich, in: Physiology, Biochemistry, and Pathology of the Endocrine System [in Russian], Kiev (1971), p. 40.Google Scholar
  4. 4.
    V. I. Kiyanov and N. N. Petrischev, in: Hemophilia and Hemorrhages Caused by Disturbance of Blood Clotting [in Russian], Leningrad (1973), p. 96.Google Scholar
  5. 5.
    T. M. Ogonovskii, in: The Blood Clotting System and Fibrinolysis [in Russian], Kiev (1969), p. 366.Google Scholar
  6. 6.
    N. N. Petrishchev, Pat. Fiziol., No. 6, 55 (1973).Google Scholar
  7. 7.
    V. T. Chkhaidze, “Changes in the functional state of blood clotting in patients' thyrotoxic goiter and a method of their correction during preoperative preparation of the patients”, Author's Abstract of Candidate's Dissertation, Tbilisi (1971).Google Scholar
  8. 8.
    J. E. Duhart, E. A. Scionico, and E. O. Micheo, Pren. Med. Argent.,57, 1889 (1970).Google Scholar
  9. 9.
    R. Gordin and B. A. Lamberg, Acta Endocrinol. (Copenhagen),19, 77 (1955).Google Scholar
  10. 10.
    E. Ikkala, A. Eisalo, and O. Heinivaare, Acta Endocrinol. (Copenhagen),40, 307 (1962).Google Scholar
  11. 11.
    J. Kiczak, M. Eisner, H. Bura, et al., Pol. Arch. Med. Wewnet.,35, 1337 (1965).Google Scholar
  12. 12.
    H. Lasch, K. Mechelke, E. Nasser, et al., Dtsch. Arch. klin. Med.,205, 131 (1958).Google Scholar
  13. 13.
    J. W. Lord and W. W. Andrus, Arch. Surg.,42, 643 (1941).Google Scholar
  14. 14.
    E. A. Loeliger, B. von der Esch, M. J. Mattern et al., Thrombos. Diathes. Haemorrh. (Stuttgart),10, 267 (1964).Google Scholar
  15. 15.
    J. Lowenthal and D. M. Fischer, Experientia (Basel),13, 253 (1957).Google Scholar
  16. 16.
    R. Nagashima, R. A. O'Reilly, and G. Levy, Clin. Pharmacol. Ther.,10, 22 (1969).Google Scholar
  17. 17.
    M. Weintraub, R. T. Breckenridge, and P. F. Griner, J. Lab. Clin. Med.,81, 273 (1973).Google Scholar

Copyright information

© Plenum Publishing Corporation 1975

Authors and Affiliations

  • N. N. Petrishchev
  • V. I. Kiyanov

There are no affiliations available

Personalised recommendations